Oracle Co. (NYSE:ORCL) Stake Cut by Lifeworks Advisors LLC

Lifeworks Advisors LLC reduced its stake in shares of Oracle Co. (NYSE:ORCL) by 1.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,869 shares of the enterprise software provider’s stock after selling 604 shares during the period. Oracle accounts for 1.3% of Lifeworks Advisors LLC’s investment portfolio, making the stock its 18th biggest holding. Lifeworks Advisors LLC’s holdings in Oracle were worth $6,453,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ORCL. Fairway Wealth LLC bought a new position in Oracle during the second quarter valued at approximately $27,000. POM Investment Strategies LLC bought a new position in shares of Oracle during the 2nd quarter valued at $30,000. Bbjs Financial Advisors LLC acquired a new stake in shares of Oracle in the 2nd quarter valued at $35,000. Koesten Hirschmann & Crabtree INC. bought a new stake in Oracle in the first quarter worth $38,000. Finally, Quest Partners LLC acquired a new position in Oracle during the second quarter worth $40,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Insider Transactions at Oracle

In other news, EVP Maria Smith sold 6,320 shares of Oracle stock in a transaction on Monday, September 16th. The stock was sold at an average price of $165.00, for a total value of $1,042,800.00. Following the completion of the sale, the executive vice president now directly owns 42,889 shares of the company’s stock, valued at approximately $7,076,685. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 42.20% of the stock is owned by company insiders.

Oracle Price Performance

Shares of Oracle stock traded down $0.69 during mid-day trading on Thursday, reaching $188.94. 1,402,731 shares of the stock were exchanged, compared to its average volume of 8,221,479. The company has a market cap of $523.56 billion, a price-to-earnings ratio of 48.87, a price-to-earnings-growth ratio of 3.49 and a beta of 1.02. Oracle Co. has a fifty-two week low of $99.26 and a fifty-two week high of $191.77. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 6.68. The firm has a 50-day simple moving average of $170.41 and a 200 day simple moving average of $145.85.

Oracle (NYSE:ORCL) last announced its earnings results on Monday, September 9th. The enterprise software provider reported $1.39 EPS for the quarter, topping the consensus estimate of $1.33 by $0.06. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The business had revenue of $13.31 billion for the quarter, compared to the consensus estimate of $13.23 billion. During the same period in the previous year, the business earned $0.95 EPS. Oracle’s revenue was up 6.9% compared to the same quarter last year. On average, sell-side analysts predict that Oracle Co. will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 24th. Shareholders of record on Thursday, October 10th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.85%. The ex-dividend date was Thursday, October 10th. Oracle’s payout ratio is presently 41.24%.

Wall Street Analysts Forecast Growth

ORCL has been the subject of several recent analyst reports. Mizuho upped their price target on Oracle from $170.00 to $185.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 10th. Citigroup upped their target price on Oracle from $140.00 to $157.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 11th. Melius Research upgraded Oracle from a “hold” rating to a “buy” rating in a report on Monday, September 16th. UBS Group restated a “market outperform” rating on shares of Oracle in a research note on Friday, October 18th. Finally, Sanford C. Bernstein raised their target price on shares of Oracle from $201.00 to $202.00 and gave the company an “outperform” rating in a research note on Monday, September 30th. Eleven equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $168.52.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.